Tubiana M - Search Results

1

Alternating chemotherapy and radiotherapy combination for bulky stage I and II intermediate and high grade non-Hodgkin lymphoma: an update.

Cosset JM, Henry-Amar M, Vuong T, Carde P, Girinsky T, Schwaab G, Droz JP, Hayat M, Tubiana M. Cosset JM, et al. Among authors: tubiana m. Radiother Oncol. 1991 Jan;20(1):30-7. doi: 10.1016/0167-8140(91)90109-t. Radiother Oncol. 1991. PMID: 2020753 Review.

2

The EORTC trials for limited stage Hodgkin's disease. The EORTC Lymphoma Cooperative Group.

Cosset JM, Henry-Amar M, Meerwaldt JH, Carde P, Noordijk EM, Thomas J, Burgers JM, Somers R, Hayat M, Tubiana M. Cosset JM, et al. Among authors: tubiana m. Eur J Cancer. 1992;28A(11):1847-50. doi: 10.1016/0959-8049(92)90018-w. Eur J Cancer. 1992. PMID: 1389523 Clinical Trial. No abstract available.

3

Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.

Friedman S, Henry-Amar M, Cosset JM, Carde P, Hayat M, Dupouy N, Tubiana M. Friedman S, et al. Among authors: tubiana m. Am J Hematol. 1991 Aug;37(4):253-7. doi: 10.1002/ajh.2830370408. Am J Hematol. 1991. PMID: 1858782

4

Pericarditis and myocardial infarctions after Hodgkin's disease therapy.

Cosset JM, Henry-Amar M, Pellae-Cosset B, Carde P, Girinski T, Tubiana M, Hayat M. Cosset JM, et al. Among authors: tubiana m. Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):447-9. doi: 10.1016/0360-3016(91)90794-5. Int J Radiat Oncol Biol Phys. 1991. PMID: 1905691

5

The value of adjunctive radiotherapy when chemotherapy is the major curative method.

Arriagada R, Cosset JM, le Chevalier T, Tubiana M. Arriagada R, et al. Among authors: tubiana m. Int J Radiat Oncol Biol Phys. 1990 Nov;19(5):1279-84. doi: 10.1016/0360-3016(90)90244-e. Int J Radiat Oncol Biol Phys. 1990. PMID: 2174841 Review.

6

Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.

Tubiana M, Henry-Amar M, Carde P, Burgers JM, Hayat M, Van der Schueren E, Noordijk EM, Tanguy A, Meerwaldt JH, Thomas J, et al. Tubiana M, et al. Blood. 1989 Jan;73(1):47-56. Blood. 1989. PMID: 2462943 Free article. Clinical Trial.

7

Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experience.

Henry-Amar M, Pellae-Cosset B, Bayle-Weisgerber C, Hayat M, Cosset JM, Carde P, Tubiana M. Henry-Amar M, et al. Among authors: tubiana m. Recent Results Cancer Res. 1989;117:270-83. doi: 10.1007/978-3-642-83781-4_30. Recent Results Cancer Res. 1989. PMID: 2602650

8

Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.

Friedman S, Henry-Amar M, Cosset JM, Carde P, Hayat M, Dupouy N, Tubiana M. Friedman S, et al. Among authors: tubiana m. J Clin Oncol. 1988 Apr;6(4):596-602. doi: 10.1200/JCO.1988.6.4.596. J Clin Oncol. 1988. PMID: 3357004

9

An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.

Cosset JM, Ozanne F, Henry-Amar M, Carde P, Amiel JL, Hayat M, Habrand JL, Tubiana M. Cosset JM, et al. Among authors: tubiana m. Radiother Oncol. 1985 Feb;3(2):133-8. doi: 10.1016/s0167-8140(85)80017-7. Radiother Oncol. 1985. PMID: 3838590

10

Ways of minimising hematopoietic damage induced by radiation and cytostatic drugs--the possible role of inhibitors.

Tubiana M, Carde P, Frindel E. Tubiana M, et al. Radiother Oncol. 1993 Oct;29(1):1-17. doi: 10.1016/0167-8140(93)90167-7. Radiother Oncol. 1993. PMID: 8295982 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

576 results

Search Page

Filters